Triglyceride/High-density Lipoprotein Cholesterol Ratio in Chronic Kidney Disease
The Prospective Cohort Study to Investigate the Role of Plasma Triglyceride/High-Density Lipoprotein Cholesterol Ratio To Predict Cardiovascular Outcomes in Chronic Kidney Disease.
1 other identifier
observational
197
1 country
1
Brief Summary
The Triglycerides (TG) to High Density Lipoprotein Cholesterol (HDL-C) ratio is a feature of insulin resistance and an independent predictor of cardiovascular risk. The investigators aimed to evaluate the relationship between TG/HDL-C ratio and the endothelial functions in patients with CKD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2009
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2013
CompletedFirst Submitted
Initial submission to the registry
April 9, 2014
CompletedFirst Posted
Study publicly available on registry
April 14, 2014
CompletedApril 14, 2014
April 1, 2014
4 years
April 9, 2014
April 10, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
All cause mortality
The COX analysis was performed in order to establish which covariates were independent predictors of cardiovascular outcomes. Kaplan Meier survival curves are generated to show the impact of the TG/HDL ratio on the cumulative survival of the cohort. The predictive power of the median TG/HDL ratio in each CKD stage for all-cause mortality and cardiovascular events are measured.
30 months
Endothelial functions assessed by flow mediated dilatation and serum ADMA measurement
The predictive role of TG/HDL ratio on endothelial functions (ADMA and flow mediated dilatation) is determined by univariate and multivariate analyses.
Once in recruitment
Eligibility Criteria
renal unit
You may qualify if:
- patients with chronic kidney disease
You may not qualify if:
- taking drugs that may influence endothelial function
- acute infections
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Gulhane School of Medicine Department of Endocrinology and Metabolism
Ankara, Ankara, 06018, Turkey (Türkiye)
Related Publications (1)
Sonmez A, Yilmaz MI, Saglam M, Unal HU, Gok M, Cetinkaya H, Karaman M, Haymana C, Eyileten T, Oguz Y, Vural A, Rizzo M, Toth PP. The role of plasma triglyceride/high-density lipoprotein cholesterol ratio to predict cardiovascular outcomes in chronic kidney disease. Lipids Health Dis. 2015 Apr 16;14:29. doi: 10.1186/s12944-015-0031-4.
PMID: 25885289DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor in Medicine
Study Record Dates
First Submitted
April 9, 2014
First Posted
April 14, 2014
Study Start
January 1, 2009
Primary Completion
January 1, 2013
Study Completion
January 1, 2013
Last Updated
April 14, 2014
Record last verified: 2014-04